SEARCH

SEARCH BY CITATION

References

  • 1
    Freter, C.E. & Cossmann, J. (1993) Angioimmunoblastic lymphadenopathy with dysproteinemia. Seminars in Oncology, 20, 627635.
  • 2
    Frizzera, G., Morgan, E.M. & Rappaport, H. (1975) Angioimmunoblastic lymphadenopathy: diagnosis and clinical course. American Journal of Medicine, 59, 803818.DOI: 10.1016/0002-9343(75)90466-0
  • 3
    Kay, A.C., Saven, A., Carrera, C.J., Carson, D.A., Thurston, D., Beutler, E. & Piro, L.D. (1992) 2-Chlorodeoxyadenosine treatment of low-grade lymphomas. Journal of Clinical Oncology, 10, 371377.
  • 4
    Knecht, H. (1989) Angioimmunoblastic lymphadenopathy: ten years' experience and state of current knowledge. Seminars in Hematology, 26, 208215.
  • 5
    Kong, L.R., Huang, C.F., Hakimian, D., Variakojis, D., Klein, L., Kuzel, T.M., Gorady, L.I., Zanzig, C., Wollins, E. & Tallman, M.S. (1998) Long term follow-up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced, indolent non-Hodgkin's lymphoma. Journal of Clinical Oncology, 82, 957964.
  • 6
    Lukes, R.J. & Tindle, B.H. (1975) Immunoblastic lymphadenopathy: a hyperimmune entity resembling Hodgkin's disease. New England Journal of Medicine, 292, 18.
  • 7
    Ong, S.T. (1996) Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia using fludarabine. Blood, 88, 23542355.
  • 8
    Sallah, S. & Bernard, S. (1996) Treatment of angioimmunoblastic lymphadenopathy with dysproteinemia using 2-chlorodeoxyadenosine. Annals of Hematology, 73, 295296.DOI: 10.1007/s002770050244
  • 9
    Sallah, S. & Gagnon, G.A. (1998) Angioimmunoblastic lymphadenopathy with dysproteinemia: emphasis on pathogenesis and treatment. Acta Haematologica, 99, 5764.DOI: 10.1159/000040811
  • 10
    Saven, A., Carrera, C.I., Carson, D.A., Beutler, E. & Piro, L.D. (1992) 2-Chlorodeoxyadenosine: an active agent in the treatment of cutaneous T-cell lymphoma. Blood, 80, 587592.
  • 11
    Seymour, J.F., Furzrock, R., Freireich, E.J. & Estey, E.H. (1990) 2-Chlorodeoxyadenosine induces durable remissions and prolonged suppression of CD4+ lymphocyte counts in patients with hairy cell leukemia. Blood, 72, 10691073.
  • 12
    Steinberg, A.D., Seldin, M.F., Jaffe, E.A., Smith, H.R., Klinman, D.M., Kreig, A.M. & Cossman, J. (1988) Angioimmunoblastic lymphadenopathy with dysproteinemia. Annals of Internal Medicine, 108, 573584.